MedTrace Logo

Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy.

NCT04694677 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-01-05

No results posted yet for this study

Summary

Uterine leiomyomas (fibroids) are the most common benign tumors among women . Fibroids are found in approximately 15% to 30% of women in the reproductive age group

Conditions

  • Myoma

Interventions

DRUG

women receiving tranexamic acid

women receiving tranexamic acid during myomectomy

DRUG

women receiving misoprostol

women receiving misoprostol in myomectomy

Sponsors & Collaborators

  • Cairo University

    collaborator OTHER

  • Aljazeera Hospital

    lead OTHER

Principal Investigators

  • Mahmoud Alalfy · Algezeera hospitaland National Research Centre ,Egypt

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-10
Primary Completion
2021-08-15
Completion
2021-09-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04694677 on ClinicalTrials.gov